Status:
COMPLETED
Effectiveness of a Postal Intervention to Improve the Use of PPI
Lead Sponsor:
Osakidetza
Conditions:
Drug Overdose
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
It was a randomised intervention study, with before-and-after outcome measures and a control group, in patients who had an active long-term prescription for PPIs at high doses for at least 6 months.
Detailed Description
The intervention consisted of sending patients an informative letter by post, in which their doctor invited them to seek an appointment for a medication review. Control group patients did not receive ...
Eligibility Criteria
Inclusion
- Patients under the care of our organisation who in May 2017 had an active long-term prescription for PPIs at high doses for at least 6 months.
Exclusion
- Patients whose GPs declined to participate
Key Trial Info
Start Date :
May 10 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 18 2018
Estimated Enrollment :
401 Patients enrolled
Trial Details
Trial ID
NCT03840018
Start Date
May 10 2017
End Date
April 18 2018
Last Update
February 15 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bidasoa Integrated Health Organization
Hondarribia, Gipuzkoa, Spain, 20270